AXA Investment Managers’s Medtronic MDT Stock Holding History

AXA Investment Managers’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$43.7M	Buy	+458,572	New	+$42.2M	0.12%	158

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXA Investment Managers's MDT Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Medtronic (MDT) in Q3 2025: 458,572 shares worth $43.7M. The stake represents 0.12% of the portfolio and ranks #158 among its holdings.

2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

AXA Investment Managers held 458,572 shares of Medtronic worth $43.7M as of Q3 2025.
Medtronic was a new AXA Investment Managers position in Q3 2025.
Medtronic made up 0.12% of AXA Investment Managers's portfolio in Q3 2025, its #158 holding.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.